Czechia, March 24 -- Czechia based CSL BEHRING s.r.o. has secured contract from Fakultni nemocnice u sv. Anny v Brne for Pharmaceutical Products - B02BB01 Human Fibrinogen; B02BD01 combination of coagulation factors IX, II, VII and X - Beriplex; B06AC01 Inhibitor, obtained from plasma. The value of the contract is worth 11607474280 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....